We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies. Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.
NEEDHAM, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal...
NEEDHAM, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal...
First-in-class multimodal immunotherapy candidate, for induction of tertiary lymphoid structures, being developed as a novel therapeutic strategy for solid tumors from the enLIGHTENβ’ Discovery...
Updated positive interim data showed notable improvements in estimated median overall survival of 28.8 months after experimental treatment with CAN-2409 versus only 12.5 months in control group in...
The first cohort of patients were treated with multiple injections of CAN-3110 in the ongoing phase 1b clinical trial.The serial procedures were well tolerated without observed dose-limiting...
On track for topline data from CAN-2409 phase 3 in localized intermediate/high risk prostate cancer, expected in Q4 2024Results from ongoing, first-in-human, phase 1b clinical trial of CAN-3110...
NEEDHAM, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.27 | 24.8046875 | 5.12 | 6.81 | 5.1 | 566772 | 6.0686917 | CS |
4 | 4.67 | 271.511627907 | 1.72 | 11.3999 | 1.56 | 16229259 | 6.59699873 | CS |
12 | 5.09 | 391.538461538 | 1.3 | 11.3999 | 1.21 | 5669485 | 6.53395516 | CS |
26 | 5.5263 | 639.840222299 | 0.8637 | 11.3999 | 0.66 | 2935185 | 6.00396112 | CS |
52 | 5.1 | 395.348837209 | 1.29 | 11.3999 | 0.66 | 1478410 | 5.96891738 | CS |
156 | -1.61 | -20.125 | 8 | 14.78 | 0.66 | 562963 | 5.9728548 | CS |
260 | -1.61 | -20.125 | 8 | 14.78 | 0.66 | 562963 | 5.9728548 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions